San Francisco startup Framework Therapeutics is usually working on an oral, the moment-everyday GLP-1 drug called GSBR-1290—the drug surpassed Wall Avenue’s expectations in June every time a mid-stage examine showed ordinary weight loss of all-around 6% and it strategies to start out An additional mid-phase demo toward the end of the year—tha… Read More